Your session is about to expire
← Back to Search
Vitamin
Arm A: Healthy Collegiate Athletes for Traumatic Brain Injury (TRMC-004 Trial)
N/A
Waitlist Available
Led By Brent A Bauer, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 84
Awards & highlights
TRMC-004 Trial Summary
This study is evaluating whether a vitamin may help improve memory and thinking skills in older adults.
Eligible Conditions
- Traumatic Brain Injury
TRMC-004 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, day 84
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 84
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in brain NAD+ levels
TRMC-004 Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Arm A: Healthy Collegiate AthletesActive Control1 Intervention
Healthy collegiate athletes will take active Nicotinamide Riboside
Group II: Arm B: Healthy Collegiate AthletesPlacebo Group1 Intervention
Healthy collegiate athletes will take a matching placebo
Find a Location
Who is running the clinical trial?
Thorne HealthTech, IncIndustry Sponsor
10 Previous Clinical Trials
650 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,754 Total Patients Enrolled
University of MinnesotaOTHER
1,377 Previous Clinical Trials
1,588,266 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger